欧盟EMA药品数据库-欧盟集中审批药品
（European Medicines Agency Authorisation of Medicines DataBase）
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
*Search by Medicine name,INN,Active substance,Product number.
高级搜索
数据记录共 2041 条，共 103 页，当前第 82 页
可点击列名称排序
商品名称 适用类别 通用名称 活性成分 产品号 上市许可持有人/公司名称 上市批准日期 授权状态
Equilis Te Veterinary Adjuvanted vaccine against tetanus tetanus toxoid EMEA/V/C/000093 Intervet International BV 2005/07/08 Authorised
Equilis Prequenza Veterinary vaccine against equine influenza in horses equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93 EMEA/V/C/000094 Intervet International BV 2005/07/08 Authorised
Equilis Prequenza Te Veterinary vaccine against equine influenza and tetanus in horses equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93, tetanus toxoid EMEA/V/C/000095 Intervet International BV 2005/07/08 Authorised
Naxcel Veterinary ceftiofur ceftiofur EMEA/V/C/000079 Zoetis Belgium SA 2005/05/19 Authorised
Aclasta Human zoledronic acid zoledronic acid EMEA/H/C/000595 Sandoz Pharmaceuticals d.d. 2005/04/15 Authorised
Aloxi Human palonosetron palonosetron hydrochloride EMEA/H/C/000563 Helsinn Birex Pharmaceuticals Ltd. 2005/03/22 Authorised
Zonegran Human zonisamide zonisamide EMEA/H/C/000577 Amdipharm Limited 2005/03/10 Authorised
Purevax RCPCh FeLV Veterinary vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), attenuated Chlamydophila felis (90 EMEA/V/C/000085 Boehringer Ingelheim Vetmedica GmbH 2005/02/23 Authorised
Purevax RCP FeLV Veterinary Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97) EMEA/V/C/000089 Boehringer Ingelheim Vetmedica GmbH 2005/02/23 Authorised
Purevax RCPCh Veterinary vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline Chlamydophila infections attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain), attenuated feline panleucopenia virus (PLI IV) EMEA/V/C/000088 Boehringer Ingelheim Vetmedica GmbH 2005/02/23 Authorised
Purevax RCP Veterinary vaccine against feline viral rhinotracheitis, feline calicivirosis and feline panleucopenia attenuated feline panleucopenia virus (PLI IV) EMEA/V/C/000090 Boehringer Ingelheim Vetmedica GmbH 2005/02/23 Authorised
Purevax RC Veterinary vaccine against feline viral rhinotracheitis and feline calicivirosis attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains) EMEA/V/C/000091 Boehringer Ingelheim Vetmedica GmbH 2005/02/23 Authorised
Purevax RCCh Veterinary vaccine against feline viral rhinotracheitis, feline calicivirosis and feline Chlamydophila infections attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain) EMEA/V/C/000092 Merial 2005/02/22 Withdrawn
Orfadin Human nitisinone nitisinone EMEA/H/C/000555 Swedish Orphan Biovitrum International AB 2005/02/21 Authorised
Prialt Human ziconotide ziconotide EMEA/H/C/000551 Esteve Pharmaceuticals GmbH 2005/02/21 Authorised
Azilect Human rasagiline rasagiline EMEA/H/C/000574 Teva B.V. 2005/02/21 Authorised
Truvada Human emtricitabine, tenofovir disoproxil emtricitabine, tenofovir disoproxil fumarate EMEA/H/C/000594 Gilead Sciences Ireland UC 2005/02/20 Authorised
Quintanrix Human diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus influenzae type B conjugate vaccine (absorbed) Diphtheria toxoid, tetanus toxoid, inactivated Bordetella pertussis, hepatitis B surface antigen (rDNA), Haemophilus influenzae type b polysaccharide EMEA/H/C/000556 GlaxoSmithKline Biologicals S.A. 2005/02/17 Withdrawn
Fendrix Human hepatitis B (rDNA) vaccine (adjuvanted, adsorbed) hepatitis B surface antigen EMEA/H/C/000550 GlaxoSmithKline Biologicals S.A. 2005/02/02 Authorised
Avastin Human bevacizumab bevacizumab EMEA/H/C/000582 Roche Registration GmbH 2005/01/12 Authorised

数据库说明：

©2006-2024 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase